David Gallardo

Girona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications

Impact of MICA-129 Mismatch on Hematopoietic Stem Cell Transplantation Outcomes: Evidence from a Large European Cohort and Meta-Analysis.

Impact of MICA-129 Mismatch on Hematopoietic Stem Cell Transplantation Outcomes: Evidence from a Large European Cohort and Meta-Analysis.

Journal: Transplantation and cellular therapy
Published: August 26, 2025

Measurable Residual Disease in UBTF-TD Adult Acute Myeloid Leukemia.

Measurable Residual Disease in UBTF-TD Adult Acute Myeloid Leukemia.

Journal: European journal of haematology
Published: November 20, 2024

Effect of NK cell receptor genetic variation on allogeneic stem cell transplantation outcome and in vitro NK cell cytotoxicity.

Effect of NK cell receptor genetic variation on allogeneic stem cell transplantation outcome and in vitro NK cell cytotoxicity.

Journal: Scientific reports
Published: March 12, 2024

Donor genetic determinant of thymopoiesis, rs2204985, and stem cell transplantation outcome in a multipopulation cohort.

Donor genetic determinant of thymopoiesis, rs2204985, and stem cell transplantation outcome in a multipopulation cohort.

Journal: Human immunology
Published: December 14, 2023

CD200 genotype is associated with clinical outcome of patients with multiple myeloma.

CD200 genotype is associated with clinical outcome of patients with multiple myeloma.

Journal: Frontiers in immunology
Published: July 03, 2023

Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma.

Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma.

Journal: Frontiers in immunology
Published: February 03, 2023

LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors.

LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors.

Journal: Frontiers in immunology
Published: October 10, 2022

Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation.

Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation.

Journal: Frontiers in immunology
Published: July 25, 2022

5'-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogenetics.

5'-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogenetics.

Journal: European journal of haematology
Published: June 23, 2022

Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapies.

Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapies.

Journal: International journal of hematology
Published: June 16, 2022

European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol.

European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol.

Journal: Blood advances
Published: June 21, 2021

Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms.

Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms.

Journal: Annals of hematology
Published: June 18, 2021
Showing 1-12 of 52

Last Updated: 09/26/2026